ceo said Data for 721 igan was going to be released around midyear , if positive easy double , could be released any day now , also preparing to file BLA for stem cell TMA , FDA said it would be the best thing to do to get it to market asap , possible end 2018 , early 2019. At pps 19 the risk dwarves the rewards , also within 10 weeks omidria starts selling again with extended reinbursement and added to VA , SO MUCH GOING ON , ITS CRAZY